Department of Energy (DOE), is offering the opportunity to enter into a collaboration partnership to further develop and commercialize its additive manufacturing processes for cellular fluidics.Background:Many biological and living systems have evolved to optimize fluidic transport.
These services include (1) performing research aimed at development, evaluation and validation of new manufacturing processes for cellular therapies (2) manufacture of cellular therapy products for approved clinical trials. The majority of these trials are early phase (I/II) trials not intended to result in the development of a commercial product.
These services include (1) performing research aimed at development, evaluation and validation of new manufacturing processes for cellular therapies (2) manufacture of cellular therapy products for approved clinical trials. The majority of these trials are early phase (I/II) 2 trials not intended to result in the development of a commercial product. CCE produces clinical therapies from cells collected from NIH CC patients and healthy donors.
Osmotic pressure is of vital importance in biology as it relates to fluid balance, nutrient transfer, and waste removal processes in all cellular organisms. The current instruments are no longer supported by the company for parts or repairs. One instrument is not fully functional. No additional workspace will be needed for this equipment.
Developing a large compendium of high-quality datasets coupled with advances in AI/ML computational techniques trained on such data and integrated within the larger scientific literature on cellular processes affords the ability to explore a more mechanistic understanding of the impact low dose radiation has on cellular function.
processes in live animals under both physiological and pathological conditions.The core supports the need for CCR investigators to perform intravital microscopy which enables it to 1) investigate the cellular mechanisms underlying tumor initiation, progression, and metastasis in live animals, 2) perform multimodal analysis of tumors, surrounding microenvironment (e.g. vasculature, extracellular matrix), dynamics and the role of the immune system
Additionally, these kits are needed to make improvements to manufacturing processes in the DTM Cellular Therapy Laboratory.
